# FORE Biotherapeutics funding: rounds and investors > FORE Biotherapeutics has raised $108M across 2 rounds since 2025. Investors include SR One, OrbiMed and Wellington Management. Every round with its source. Source: https://millionrounds.com/company/fore-biotherapeutics (Millionrounds; every figure on the page links to its filing or article) United States · [Series D startup](https://millionrounds.com/companies) # Who invested in *FORE Biotherapeutics* 2 rounds we have observed, with the 16 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Pharma Raised 4 months ago Follow FORE Biotherapeutics and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fcompany%2Ffore-biotherapeutics) Funding summary Updated 5 Nov 2026 **$108M** raised across 2 rounds since 2025, from 3 sources **$40M** Series D **$67M** Series D - **Latest round:** Series D, $67M Jul 2026 - **Led by:** SR One and Medicxi and 1 more - **Step-up i:** 1.7× - **Investors:** 16 (3 led) See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2026 **$40M** Series D **$67M** Series D - **First round:** Series D, $40M - **Biggest round:** $67M - **Between rounds:** 14 months ## The rounds - **Jul 2026** Series D **$67M** *12 new* *4 returning* [SR One](https://millionrounds.com/fund/sr-one) Lead [Medicxi](https://millionrounds.com/fund/medicxi) Lead [SymBiosis](https://millionrounds.com/fund/symbiosis) Lead [OrbiMed](https://millionrounds.com/fund/orbimed) [Wellington Management](https://millionrounds.com/fund/wellington-management) [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) [Novartis Venture Fund](https://millionrounds.com/fund/novartis-venture-fund) [Samsung](https://millionrounds.com/fund/samsung) [Cormorant Capital](https://millionrounds.com/fund/cormorant-capital) [LG](https://millionrounds.com/fund/lg-technology-ventures) [HBM Healthcare Investments](https://millionrounds.com/fund/hbm-healthcare-investments) [Axil](https://millionrounds.com/fund/axil) [Primer Ventures](https://millionrounds.com/fund/primer-ventures) [3B Capital](https://millionrounds.com/fund/3b-capital) [TaiAx](https://millionrounds.com/fund/taiax) [Windham Life Science Partners](https://millionrounds.com/fund/windham-life-science-partners) Reported by Ventureburn and 1 other - **May 2025** Series D **$40M** *4 new* [OrbiMed](https://millionrounds.com/fund/orbimed) [Wellington Management](https://millionrounds.com/fund/wellington-management) [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) [SR One](https://millionrounds.com/fund/sr-one) Source recorded ## Founders and team From FORE Biotherapeutics's own website: 3 on the team. - **Michael Byrnes** Chief Financial Officer - **Rajeev Dadoo** COO and Managing Partner of SR One - **Dieter Weinand** Chairman of the Board ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series D** 2025 **Series D** 2026 [SR One](https://millionrounds.com/fund/sr-one) L [OrbiMed](https://millionrounds.com/fund/orbimed) [Wellington Management](https://millionrounds.com/fund/wellington-management) [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) [Medicxi](https://millionrounds.com/fund/medicxi) L [SymBiosis](https://millionrounds.com/fund/symbiosis) L [Novartis Venture Fund](https://millionrounds.com/fund/novartis-venture-fund) [Samsung](https://millionrounds.com/fund/samsung) [Cormorant Capital](https://millionrounds.com/fund/cormorant-capital) [LG](https://millionrounds.com/fund/lg-technology-ventures) ## Everyone who backed them [SR One](https://millionrounds.com/fund/sr-one) Corporate VC **2** rounds, led 1 [OrbiMed](https://millionrounds.com/fund/orbimed) Private equity **2** rounds [Wellington Management](https://millionrounds.com/fund/wellington-management) VC firm **2** rounds [Cormorant Asset Management](https://millionrounds.com/fund/cormorant-asset-management) Private equity **2** rounds [Medicxi](https://millionrounds.com/fund/medicxi) VC firm **1** round, led 1 [SymBiosis](https://millionrounds.com/fund/symbiosis) VC firm **1** round, led 1 [Novartis Venture Fund](https://millionrounds.com/fund/novartis-venture-fund) Corporate VC **1** round [Samsung](https://millionrounds.com/fund/samsung) VC firm **1** round [Cormorant Capital](https://millionrounds.com/fund/cormorant-capital) VC firm **1** round [LG](https://millionrounds.com/fund/lg-technology-ventures) Corporate VC **1** round [HBM Healthcare Investments](https://millionrounds.com/fund/hbm-healthcare-investments) VC firm **1** round [Axil](https://millionrounds.com/fund/axil) Growth equity **1** round [Primer Ventures](https://millionrounds.com/fund/primer-ventures) VC firm **1** round [3B Capital](https://millionrounds.com/fund/3b-capital) Growth equity **1** round [TaiAx](https://millionrounds.com/fund/taiax) Growth equity **1** round [Windham Life Science Partners](https://millionrounds.com/fund/windham-life-science-partners) Growth equity **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=fore-biotherapeutics). ## Also claim to have backed them This firm lists FORE Biotherapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above. [Windham Capital Partners](https://millionrounds.com/fund/windham-capital-partners) Growth equity Per its own site ## Quick answers about FORE Biotherapeutics ### Who invested in FORE Biotherapeutics? FORE Biotherapeutics's investors include SR One, OrbiMed, Wellington Management, Cormorant Asset Management and Medicxi, and 11 more on record. SR One led its latest round. ### How much has FORE Biotherapeutics raised? FORE Biotherapeutics has raised $108M across 2 rounds since 2025. ### When did FORE Biotherapeutics last raise? FORE Biotherapeutics's most recent round was a Series D of $67M in Jul 2026, led by SR One. ### What was FORE Biotherapeutics's biggest round? Its most recent round, $67M in Jul 2026, is also its largest on record. ### Who backed FORE Biotherapeutics first? FORE Biotherapeutics's first round on record, in May 2025, was backed by OrbiMed, Wellington Management and Cormorant Asset Management and 1 others. ### What stage is FORE Biotherapeutics at? FORE Biotherapeutics's latest named round is a Series D, in Jul 2026. ### Where is FORE Biotherapeutics based? FORE Biotherapeutics is based in the United States. ### Who led FORE Biotherapeutics's rounds? SR One led the Series D in 2026. ## Companies like FORE Biotherapeutics In the same sector, and raised in the last eighteen months. [**GPN Vaccines** $10B · Nov 2026](https://millionrounds.com/company/gpn-vaccines)[**Omni** $244M · Nov 2026](https://millionrounds.com/company/omni)[**General Medicine** $152M · Nov 2026](https://millionrounds.com/company/general-medicine)[**Midstream Health** $27M · Oct 2026](https://millionrounds.com/company/midstream-health)[**Verisma** Oct 2026](https://millionrounds.com/company/verisma)[**Urologic Design** $1.2M · Oct 2026](https://millionrounds.com/company/urologic-design) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app